Medefer, the b2b virtual healthcare provider that is reimagining the old-fashioned outpatient system, has announced a £10m funding round led by private investment firm Nickleby Capital. The growth funding will be used to invest in people and technology to service new contracts, enable new product development and ensure scalable and robust growth from its strong pipeline. The company, founded by NHS consultant Dr Bahman Nedjat-Shokouhi - who still works in the NHS - has been recognised as one of the top 100 most exciting digital health companies in the UK, by the DTI.   

A healthtech business with an app that helps patients communicate with clinicians remotely has raised a further £2m to help expand its use.

Advanced Digital Innovation (ADI) has raised funding from NPIF – Mercia Equity Finance, which is managed by Mercia and is part of the Northern Powerhouse Investment Fund, the UK government’s Future Fund and the company’s Chair and founder Bob Gomersall.

Advanced Digital Innovation (ADI) has raised funding from NPIF – Mercia Equity Finance, which is managed by Mercia and is part of the Northern Powerhouse Investment Fund, the UK government’s Future Fund and the company’s Chair and founder Bob Gomersall.  The Yorkshire-based company says the pandemic has boosted interest in its MyPathway app, which removes the need for appointment letters and calls, allowing patients to agree care plans with clinicians, who can then monitor their progress and receive feedback.

Liopa has successfully achieved funding from Innovate UK in its “Funding Competition for Business-led Innovation in Response to Global Disruption.” The financial award is part of a £40m package from the UK government to bolster technology and research-focused companies who are working to build resilience during the Covid crisis. 

A biotech company which is developing new treatments for patients with serious spinal conditions has completed a £2.25m funding round led by Mercia Asset Management to help to continue its ground-breaking research and bring its first products to market.

Neurovalens, a global healthtech company headquartered in Belfast and San Diego, has raised £5.1 million in funding, led by IQ Capital. Wharton Asset Management Company, The Angel CoFund (ACF), Techstart Ventures, Clarendon Fund Managers, and the Government’s Future Fund also contributed to the funding round, which will be used to expand on the success of Neurovalens’ initial clinical trials and develop the technology’s application for other conditions.

Leading digital health start-up Gendius has raised £250,000 on leading crowdfunding platform, Crowdcube, as downloads of its remote diabetes platform for diabetes, Intellin®, have also reached 250,000. Gendius has now overfunded on Crowdcube by over 500% 

Macomics Ltd, an immuno-oncology company with world-leading expertise in macrophage biology, launches today with a £3.2 million seed financing round led by transatlantic VC Epidarex Capital, with the Scottish Investment Bank, the investment arm of Scottish Enterprise, also investing. Company formation and in-licensing of the technology has been facilitated by Edinburgh Innovations, the commercialisation service for the University of Edinburgh. Macomics, which was spun out from the University of Edinburgh, will use the proceeds of this fundraising round to develop novel, first-in-class immunotherapies designed to modulate macrophages, increasing the body’s immune defence against tumours. 

Kelvin Capital backed ProFactor Pharma Ltd (PFP), has completed an important development milestone in its research that will transform the treatment of ‘Haemophilia A’.

Based outside Edinburgh at the Easter Bush Campus, the company has received £1.1m (the second tranche of funding from its £2m funding round announced in September 2019) to advance its R&D programme, which is moving closer to toxicology studies for its low cost recombinant human factor VIII (rhFVIII) for the treatment of ‘Haemophilia A’.

A team of healthcare experts who developed a fast and low-cost way to protect carers working with Covid-19 patients has raised a £100,000 investment.

Mat Campbell-Hill and his colleagues who created the AerosolShield mini-isolation tent have secured the funding from the West Midlands Academic Health Science Network’s (WMAHSN) SME Health Innovation Fund, which is managed by Mercia, and MidTECH Innovations.

Beckley Psytech, the psychedelic medicine company, has raised £3m of Series A funding to develop a pipeline of psychedelic drugs into licensed pharmaceutical medicines for treating psychiatric and neurological diseases. Investors in the round include prominent British businessmen Jim Mellon and Richard Reed, co-founder of Innocent Drinks.

The Beckley Psytech team comprises talent from the psychedelic and pharmaceutical fields. It was co-founded by world-renowned leader in psychedelic research Lady Amanda Feilding and CEO Cosmo Feilding Mellen.

Covid-19 has made investment prospects bleak in many sectors, but a new report by Ceuta Group reveals confidence in consumer health, wellness and personal care remains high despite economic turmoil.

Ceuta Group’s report ‘The Enduring Appeal Of Investment In Healthcare & Wellness Consumer Brands’ argues that health and personal care is one of the few industries that is “pandemic proof”.